{"transactions":[{"id":725714,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35222,"kind":"person","name":"Fawell Stephen","position":1,"cik":"0002033387","reported_name":"Fawell Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T20:27:23.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":62000,"derivative":{"exercise_price":4.25,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001470831-26-000659","document":"wk-form4_1782505640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033387/000147083126000659/wk-form4_1782505640.xml","form_type":"4"}},{"id":1105238,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35222,"kind":"person","name":"Fawell Stephen","position":1,"cik":"0002033387","reported_name":"Fawell Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:11:39.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":35500,"derivative":{"exercise_price":1.44,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001662579-25-000047","document":"wk-form4_1750450293.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033387/000166257925000047/wk-form4_1750450293.xml","form_type":"4"}},{"id":1417941,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":35222,"kind":"person","name":"Fawell Stephen","position":1,"cik":"0002033387","reported_name":"Fawell Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-03T20:52:31.000Z","date":"2024-08-29","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares underlying this option shall vest and become exercisable on August 29, 2025, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":65000,"derivative":{"exercise_price":6.43,"expiration_date":"2034-08-28","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001662579-24-000072","document":"wk-form4_1725396745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033387/000166257924000072/wk-form4_1725396745.xml","form_type":"4"}}]}